Lynx1 Capital Management LP - 10%+ Owner at TScan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: 10%+ Owner
Stock Symbol: TCRX on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Lynx1 Capital Management LP - trading volume in the past year for TScan Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+5M	100%	$7.13	+$35.6M
Sells
Net	+5M	100%		+$35.6M

Holdings reported by Lynx1 Capital Management LP for TScan Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Pre-funded Warrant (right to buy)	5M	$35.6M	$7.13	Apr 19, 2024	Indirect	Common Stock
Common stock, $0.0001 par value per share Common Stock	5.24M	$13.2M	$2.51	May 31, 2023	Indirect
Common Stock	5.22M	$13.1M	$2.51	May 31, 2023	Indirect
Common stock, $0.0001 par value per share	5.25M			May 31, 2023	Indirect

Transactions reported by Lynx1 Capital Management LP for TScan Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.